Estrogen induces nitric oxide-mediated vasodilation of human mammary arteries in vitro

Nitric Oxide - Biology and Chemistry

Volumn 2, Issue 6, 1998, Pages 460-466

  Nechmad, Allon ^a   Merin, Gideon ^a   Schwalb, Herzl ^a   Shimon, Dov V ^a   Borman, Joseph B ^a   Milgalter, Eli ^a   Mosseri, Morris ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Endothelium; Estrogen; Mammary artery; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; TAMOXIFEN;

ADULT; AGED; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM INJURY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTERNAL MAMMARY ARTERY; MALE; PRIORITY JOURNAL;

IMA;

EID: 0032436822     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.1998.0202     Document Type: Article

References (43)

1. Puga J. The use of the internal mammary artery for revascularization of the left anterior descending coronary artery. Eur. Heart J. 16:1995;E21-E25.
2. Rupprecht H. J., Hamm C., Ischinger T., Dietz U., Reimers J., Meyer J. Angiographic follow-up results of a randomized study on angioplasty versus bypass surgery (GABI Trial). Eur. Heart J. 17:1966;1192-1198.
3. Godsland I. F., Wynn V., Crook D., Miller N. E. Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questions. Am. Heart J. 114:1987;1467-1503.
4. Barrett-Connor E., Bush T. L. Estrogen and coronary heart disease in women. J. Am. Med. Assoc. 265:1991;1861-1867.
5. Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen therapy and cardiovascular disease: Ten year follow up from the Nurses' Health Study. N. Engl. J. Med. 325:1991;756-762.
6. Knopp R. H. The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Obstet. Genecol. 72:1988;23S-30S.
7. Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen therapy and cardiovascular disease. N. Engl. Med. J. 325:1991;756-762.
8. Vito J. A., Treasure C. B., Nabel E. G., McLenachan J. M., Fish D., Yeung A. C., Vekshtein V. I., Selwyn A. P., Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary disease. Circulation. 81:1990;491-497.
9. Ivert T., Huttenen K., Landou C., Bjork V. O. Angiographic studies of internal mammary artery grafts 11 years after coronary artery bypass grafting. J. Thorac. Surg. 96:1988;1-12.
10. Barner H. B., Barnett M. G. Fifteen- to twenty-one year angiographic assessment of internal thoracic artery as a bypass conduit. Ann. Thorac. Surg. 57:1994;1526-1528.
11. Grondin C. M., Campeau L., Thornton J. C., Engle J. C., Cross F. S., Schriber H. Coronary artery bypass grafting with saphenous vein. Circulation. 79:1989;24-29.
12. Loop F. D., Lytle B. W., Cosgrove D. M., Stewart R. W., Goormastic M., Williams G. W. Influence of internal mammary artery graft on 10-year survival and other cardiac events. N. Engl. J. Med. 314:1986;1-6.
13. Cameron A. A., Green G. E., Brogno D. A., Thornton J. Internal artery thoracic grafts: 20-year clinical follow-up. J. Am. Coll. Cardiol. 25:1995;188-192.
14. Boylan M. L., Lytle B. W., Loop F. D., Taylor P. C., Borsh J. A., Goormastic M. Surgical treatment of isolated left anterior descending coronary stenosis. Comparison of internal mammary artery and venous autograft at 18 and 20 years of follow-up. J. Thorac. Cardiovasc. Surg. 107:1994;657-662.
15. Luscher T. F., Diederich D., Siebenmann R., Lehmann K., Stulz P., Von Seggeser L. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N. Engl. J. Med. 319:1988;462-467.
16. Angelini G. D., Christie M. I., Bryan A. J., Lewis M. J. Surgical preparation impairs release of endothelium-derived relaxing factor from human saphenous vein. Ann. Thorac. Surg. 48:1989;417-420.
17. Radomski M. W., Palmer R. M. J., Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. Heart Pharmacol. 92:1987;639-646.
18. Stumpf W. E., Sar M., Aumuller G. The heart: A target organ for estradiol. Science. 196:1977;319-321.
19. Lin A. L., Gonzalez R., Carey K. D., Shain S. A. Estradiol-17β affects estrogen receptor distribution and elevates progesterone receptor content in baboon aorta. Arteriosclerosis. 6:1986;495-504.
20. Ingegno M. D., Money S. R., Thelmo W. Progesterone receptors in the human heart and great vessels. Lab. Invest. 59:1988;353-356.
21. Lieberman E. H., Gerhard M. D., Uehata A., Walsh B. W., Sefwyn A. P., Ganz P., Yeung A. C., Creager M. A. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann. Intern. Med. 121:1994;936-941.
22. Hayashi T., Fukuto J. M., Ignarro L. J., Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis. Proc. Natl. Acad. Sci. USA. 89:1992;11259-11263.
23. Jiang C., Sarrel P. M., Lindsay D. C., Poole-Wilson P. A., Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17-β-estradiol in vitro. Br. J. Pharmacol. 104:1991;1033-1037.
24. Collins P., Shay J., Jiang C., Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation. 90:1994;1964-1968.
25. Williams J. K., Adams M. R., Klopfenstein H. S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 81:1990;1680-1687.
26. Miller V. M., Vanhoutte P. M. 17-β-Estradiol augments endothelium-dependent contractions to arachidonic acid in rabbit aorta. Am. J. Physiol. 258:1990;R1502-R1507.
27. Jiang C., Sarrel P. M., Poole-Wilson P. A., Collins P. Acute effect of 17-β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am. J. Physiol. 263:1992;H271-H275.
28. Bell D. R., Rensberger H. J., Koritnik D. R., Koshy A. Estrogen pretreatment directly potentiates endothelium dependent vasorelaxation of porcine coronary arteries. Am. J. Physiol. 268:1995;H377-H383.
29. Gisclard V., Miller V. M., Vanhoutte P. M. Effect of 17-β-estradiol on endothelium-dependent responses in the rabbit. J. Pharm. Exp. Ther. 244:1987;19-22.
30. Williams J. K., Adams M. R., Herrington D. M., Clarkson T. B. Short term of estrogen and vascular responses of atherosclerotic coronary arteries. J. Am. Coll. Cardiol. 20:1992;452-457.
31. Cheng D. Y., Gruetter C. A. Chronic estrogen alters responsiveness to angiotensin II and norepinephrine in female rat aorta. Eur. J. Pharmacol. 215:1992;171-176.
32. Magness R. R., Rosenfeld C. R. Local and systemic 17-β-estradiol: Effects on uterine and systemic vasodilation. Am. J. Physiol. 256:1989;E536-542.
33. Van Buren G. A., Yang D., Clark K. E. Estrogen-induced uterine vasodilation is antagonized byL. Am. J. Obstet. Gynecol. 167:1992;828-833.
34. Veille J. C., Li Ping, Eisenbach J. C., Massmann A. G., Figueroa J. P. Effects of estrogen on nitric oxide biosynthesis and vasorelaxant activity in sheep uterine and renal arteries in vitro. Am. J. Obstet. Gynecol. 174:1996;1043-1049.
35. Mugge A., Riedel M., Barton M., Kuhn M., Lichtlen P. R. Endothelium-independent relaxation of human coronary arteries by 17-β-estradiol in vitro. Cardiovasc. Res. 27:1993;1939-1942.
36. Gilligan D. M., Badar D. A., Guetta V., Quyyumi A. A., Panza J. A., Cannon R. O. Estradiol potentiation of endothelium-dependent vasodilation is dependent on nitric oxide production. J. Am. Coll. Cardiol. 23:1994;378A.
37. Reis S. E., Gloth S. T., Blumenthal R. S., Resar J. R., Zacur H. A., Gerstenblith G., Brinker J. A. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 89:1994;52-60.
38. Lieberman E. H., Gerhard M. D., Uehata A., Walsh B. W., Selwyn A. P., Ganz P., Yeung A. C., Creager M. A. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann. Intern. Med. 121:1994;936-941.
39. Collins P., Rosano G. M. C., Sarrel P., Ulrich L., Adamopoulos S., Beale C. M., McNeill J. G., Poole-Wilson P. A. 17-β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 92:1995;24-30.
40. Gilligan D. M., Quyyumi Cannon R. O. III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 89:1994;2545-2551.
41. Raddino R., Manca C., Poli E., Bolognesi R., Visioli O. Effects of 17-β-Estradiol on the isolated rabbit heart. Arch. Int. Pharmacol. 281:1986;57-65.
42. Collins P., Rosano G. M. C., Jiang C., Lindsay D., Sarrel P. M., Poole-Wilson P. A. Cardiovascular protection by estrogen-a calcium antagonist effect? Lancet. 341:1993;1264-1265.
43. Lin A. L., Shain S. A. Estrogen mediated cytoplasmic and nuclear distribution of rat cardiovascular estrogen receptors. Arteriosclerosis. 5:1985;668-677.